Feedback

TOPIC

Psychedelic Research

While the use of psychedelic substances dates back to ancient times, research into their effects and uses was effectively shut down until recently. LSD was first discovered in 1943, and a significant interest developed in the potential psychotherapeutic uses of it and other psychedelic drugs; however, with the rise of the 1960s counterculture movement and its adaptation of psychedelics as an act of rebellion against society, the drugs were deemed dangerous, made illegal, and effectively banned from research. Modern researchers are once again delving into their potential benefits in treating a multitude of issues—from anxiety, depression, and PTSD, to brain injury and even the fear of death associated with terminal cancer.

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.

DMT Models the Near-Death Experience

Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).

Largest Ever DMT Survey Travels to the Fringes of Psychedelic Science

Encounters with inter-dimensional beings, atheists discovering belief, and the bizarre world of DMT-induced entities. A trip to the fringes of psychedelic science.

Mind Molding Psychedelic Drugs Could Treat Depression, and Other Mental Illnesses

It seems that psychedelics do more than simply alter perception. According to the latest research from my colleagues and me, they change the structures of neurons themselves.

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Using pharmacokinetic modeling and DMT blood sampling data, we demonstrate that the unique pharmacological characteristics of DMT, which also include a rapid onset and lack of acute tolerance to its subjective effects, make it amenable to administration by target-controlled intravenous infusion.

Near-Death Experiences and DMT

A neurological explanation of NDEs remains elusive.

DMT, Aliens, and Reality—Part 1

Psychedelic drug phenomena do not justify radical new views of reality.

Does DMT Model the Near-Death Experience?

Despite parallels, there are profound differences between DMT and NDEs.

Do Our Brains Produce DMT, and If So, Why?

For such a simple and widespread molecule, N, N-Dimethyltryptamine (DMT) has done a remarkably good job at frustrating scientists.

Rick Strassman on DMT and the Mystical State

Before we claim that spiritual experiences heal, we must agree on what a spiritual experience is.

UP NEXT

Psychedelic-Assisted Therapy